Brief: Polaryx Therapeutics Closes $10 Million Private Placement Equity Financing
28/05/2026 13:37
BRIEF-Polaryx Therapeutics Closes $10 Million Private Placement Equity Financing May 28 (Reuters) - Polaryx Therapeutics, Inc PLYX.O:
ANNOUNCES CLOSING OF $10 MILLION PRIVATE PLACEMENT EQUITY FINANCING TO SUPPORT LAUNCH OF SOTERIA PHASE 2 BASKET TRIAL
Source text: ID:nGNE5TFg16
Further company coverage: PLYX.O
((Reutersbriefs@thomsonreuters.com;))
Recent news on Polaryx Therapeutics
See all newsBrief: Polaryx Therapeutics Closes $10 Million Private Placement Equity Financing
U.S. STOCKS ON THE MOVE-Northern Trust, UnitedHealth, Tractor Supply
U.S. STOCKS ON THE MOVE-Intel, Teradyne, MSCI
Polaryx rises after FDA grants fast-track status for rare disease drug
Brief: Polaryx Therapeutics Receives U.S. FDA Fast Track Designations For All Four Indications To Be Evaluated In The Soteria Basket Trial